| Metric | შპს ფარმედ | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾79.5m₾58.0m | ₾2.36bn₾2.11bn |
| Revenue growth | 37.1% | 11.8% |
| Profitability | ||
| EBITDA | ₾24.7m₾15.3m | — |
| EBITDA margin | 31.1%26.3% | — |
| Net profit | ₾25.2m₾17.2m | ₾1.24bn₾1.12bn |
| Net margin | 31.7%29.6% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾90.4m₾67.5m | ₾37.66bn₾31.77bn |
| Total equity | ₾77.5m₾52.3m | ₾5.45bn₾4.75bn |
| ROE | 32.5%32.8% | 22.8%23.6% |